Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Testosterone and Estrogen in Vulvodynia
NCT07260825Phase 3Not yet recruiting
- Sponsor
- TriHealth
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in vulvodynia, dyspareunia, sponsored by TriHealth. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Testosterone TEPI patch
03
Conditions
vulvodyniadyspareunia
Beyond the preview
Go deeper on NCT07260825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07260825.